Beneficial effect of soy isoflavones on bone mineral content was modified by years since menopause, body weight, and calcium intake: A double-blind, randomized, controlled trial

Menopause

Volumn 11, Issue 3, 2004, Pages 246-254

  Chen, Yu Ming ^a,d   Ho, Suzanne C ^a,e   Lam, Silvia S H ^a   Ho, Susan S S ^b   Woo, Jean L F ^c  

^a Dept of Comm and Family Medicine ^*  (Hong Kong)

^b School of Pharmacy   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d SUN YAT SEN UNIVERSITY   (China)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Body weight; Bone mineral content; Dietary calcium; Postmenopause; Soy isoflavones; Years since menopause

Indexed keywords

CALCIUM; ESTROGEN; ISOFLAVONE DERIVATIVE; PLACEBO; SOYBEAN PROTEIN;

ADULT; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE MINERAL; CALCIUM INTAKE; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HIP; HUMAN; MENOPAUSE; OSTEOLYSIS; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SOYBEAN; SPINE; MIDDLE AGED; PHYTOTHERAPY; POSTMENOPAUSE OSTEOPOROSIS; RADIODENSITOMETRY; TREATMENT OUTCOME;

BODY WEIGHT; BONE DENSITY; CALCIUM, DIETARY; DENSITOMETRY, X-RAY; DIETARY SUPPLEMENTS; FEMALE; HUMANS; ISOFLAVONES; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PHYTOTHERAPY; SOYBEAN PROTEINS; TREATMENT OUTCOME;

EID: 4043102053     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GME.0000094394.59028.46     Document Type: Article

References (44)

1. Ho SC, Woo JL, Leung SS, Sham AL, Lam TH, Janus ED. Intake of soy products is associated with better plasma lipid profiles in the Hong Kong Chinese population. J Nutr 2000;130:2590-259 3.
2. Lichtenstein AH. Soy protein, isoflavones and cardiovascular disease risk. J Nutr 1998;128:1589-1592.
3. Anderson JJ, Garner SC. Phytoestrogens and bone. Baillieres Clin Endocrinol Metab 1998;12:543-557.
4. Scheiber MD, Rebar RW. Isoflavones and postmenopausal bone health: a viable alternative to estrogen therapy? Menopause 1999;6:233-241.
5. Adlercreutz CH, Goldin BR, Gorbach SL, et al. Soybean phytoestrogen intake and cancer risk. J Nutr 1995;125:757S-770S.
6. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol 2002;3:364-373.
7. Arjmandi BH, Getlinger MJ, Goyal NV, et al. Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats. Am J Clin Nutr 1998;68:1358S-1363S.
8. Draper CR, Edel MJ, Dick IM, Randall AG, Martin GB, Prince RL. Phytoestrogens reduce bone loss and bone resorption in oophorectomized rats. J Nutr 1997;127:1795-1799.
9. Chen YM, Ho SC, Lam SS, Ho SS, Woo JL. Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind randomized, controlled trial. J Clin Endocrinol Metab 2003;88:4740-4747.
10. Ishimi Y, Miyaura C, Ohmura M, et al. Selective effects of genistein, a soybean isoflavone, on B- lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology 1999;140:1893-1900.
11. Picherit C, Coxam V, Bennetau-Pelissero C, et al. Daidzein is more efficient than genistein in preventing ovariectomy- induced bone loss in rats. J Nutr 2000;130:1675-1681.
12. Horiuchi T, Onouchi T, Takahashi M, Ito H, Orimo H. Effect of soy protein on bone metabolism in postmenopausal Japanese women. Osteoporos Int 2000;11:721-724.
13. Greendale GA, FitzGerald G, Huang MH, et al. Dietary soy isoflavones and bone mineral density: results from the study of women's health across the nation. Am J Epidemiol 2002;155:746-754.
14. Mei J, Yeung SS, Kung AW. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 2001;86:5217-5221.
15. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 2000;72:844-852.
16. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW, Jr. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998;68:1375S-1379S.
17. Clifton-Bligh PB, Baber RJ, Fulcher GR, Nery ML, Moreton T. The effect of isoflavone's extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause 2001;8:259-265.
18. Hsu CS, Shen WW, Hsueh YM, Yeh SL. Soy isoflavone supplementation in postmenopausal women. Effects on plasma lipids, antioxidant enzyme activities and bone density. J Reprod Med 2001;46:221-226.
19. Meema S, Meema HE. Menopausal bone loss and estrogen replacement. Isr J Med Sci 1976;12:601-606.
20. Brot C, Jensen LB, Sorensen OH. Bone mass and risk factors for bone loss in perimenopausal Danish women. J Intern Med 1997;242:505-511.
21. Ho SC, Leung P.C. Determinants of peak bone mass in Chinese and Caucasian populations. HKMJ 1995;1:38-42.
22. Glauber HS, Vollmer WM, Nevitt MC, Ensrud KE, Orwoll ES. Body weight versus body fat distribution, adiposity, and frame size as predictors of bone density. J Clin Endocrinol Metab 1995;80:1118-1123.
23. Heaney RP. Nutrition and risk for osteoporosis. In: Marcus R, Feldman D, Kelsey J, ed. Osteoporosis. San Diego: Academic Press, 2001:669-700.
24. U.S. Department of Health, Education and Welfare and Food & Agriculture Organization of the United Nations. Food Composition Table for Use in East Asia. 1972.
25. Wang GY, ed. Food Composition Tables (in Chinese). Beijing, China: People's Medical Publishing House, 1991.
26. Adlercreutz H, Mazur W. Phyto-oestrogens and western diseases. Ann Med 1997;29:95-120.
27. Tham DM, Gardner CD, Haskell WL. Clinical review 97: Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 1998;83:2223-2235.
28. Glazier MG, Bowman MA. A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch Intern Med 2001;161:1161-1172.
29. Heaney RP. Bone mass, nutrition, and other lifestyle factors. Nutr Rev 1996;54:S3-S10.
30. Peacock M, Selby PL, Prancis RM, Taylor Ga. The action and biological significance of female and male sex steroids on plasma total and free 1,25(OH)2 D, parathyoid hormone and calcitoin. In: Norman AW, Schaefer K, Grigoleit HT, Herrath DV, ed. Vitamin D: Chemical. Biochemical and Clinical Update. Berlin: Gruyter, 1985:595-596.
31. Recker R, Lappe J, Davies K, Heaney R. Characterization of perimenopausal bone loss: a prospective study. J Bone Miner Res 2000;15:1965-1973.
32. Heaney RP, Gallagher JC, Johnston CC, Neer R, Parfitt AM, Whedon GD. Calcium nutrition and bone health in the elderly. Am J Clin Nutr 1982;36:986-1013.
33. Mackerras D, Lumley T. First- and second-year effects in trials of calcium supplementation on the loss of bone density in postmenopausal women. Bone 1997;21:527-533.
34. Shea B, Wells G, Cranney A, et al. Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta- analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev 2002;23:552-559.
35. Dawson-Hughes B, Jacques P, Shipp C. Dietary calcium intake and bone loss from the spine in healthy postmenopausal women. Am J Clin Nutr 1987;46:685-687.
36. Devine A, Criddle RA, Dick IM, Kerr DA, Prince RL. A longitudinal study of the effect of sodium and calcium intakes on regional bone density in postmenopausal women. Am J Clin Nutr 1995;62:740-745.
37. van Beresteijn EC, van't Hof MA, Schaafsma G, de Waard H, Duursma SA. Habitual dietary calcium intake and cortical bone loss in perimenopausal women: a longitudinal study. Calcif Tissue Int 1990;47:338-344.
38. Stevenson JC, Whitehead MI, Padwick M, et al. Dietary intake of calcium and postmenopausal bone loss. BMJ 1988;297:15-17.
39. Riggs BL, Wahner HW, Melton LJ III, Richelson LS, Judd HL, O'Fallon WM. Dietary calcium intake and rates of bone loss in women. J Clin Invest 1987;80:979-982.
40. Arjmandi BH, Khalil DA, Smith BJ, et al Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab 2003;88:1048-1054.
41. Landin-Wilhelmsen K, Nilsson A, Bosaeus I, Bengtsson BA. Growth hormone increases bone mineral content in postmenopausal osteoporosis: a randomized placebo-controlled trial. J Bone Miner Res 2003;18:393-405.
42. Rosen CJ, Wuster C. Growth hormone rising: did we quit too quickly? J Bone Miner Res 2003;18:406-409.
43. Sugimoto T, Nishiyama K, Kuribayashi F, Chihara K. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures. J Bone Miner Res 1997;12:1272-1279.
44. Boonen S, Lesaffre E, Dequeker J, et al. Relationship between base-line insulin-like growth factor-I (IGF-I) and femoral bone density in women aged over 70 years: potential implications for the prevention of age-related bone loss. JAm Geriatr Soc 1996;44:1301-1306.